Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Investment Income: 2022-2024

Historic Non Operating Investment Income for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to -$14,000.

  • Biofrontera's Non Operating Investment Income rose 150.00% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17,000, marking a year-over-year increase of 97.87%. This contributed to the annual value of -$14,000 for FY2024, which is 99.81% up from last year.
  • Latest data reveals that Biofrontera reported Non Operating Investment Income of -$14,000 as of FY2024, which was up 99.81% from -$7.4 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Non Operating Investment Income ranged from a high of $1.7 million in FY2022 and a low of -$7.4 million during FY2023.
  • For the 3-year period, Biofrontera's Non Operating Investment Income averaged around -$1.9 million, with its median value being -$14,000 (2024).
  • As far as peak fluctuations go, Biofrontera's Non Operating Investment Income tumbled by 524.79% in 2023, and later skyrocketed by 99.81% in 2024.
  • MRY analysis of 3 years shows Biofrontera's Non Operating Investment Income stood at $1.7 million in 2022, then plummeted by 524.79% to -$7.4 million in 2023, then skyrocketed by 99.81% to -$14,000 in 2024.
  • Its Non Operating Investment Income stands at -$14,000 for FY2024, versus -$7.4 million for FY2023 and $1.7 million for FY2022.